Indexed in Journament

Cancer medicine

ISSN 2045-7634· EN

Certificate of Indexing
Login or register to claim ownership or editorship of this journal.
38.2 / 100
Journament Score
Poor
Ranked #10,051 of 29,341 scored journals (33,995 indexed)
22 Articles
Scores higher than 65.7% of scored journals
050100
The Journament Score is computed from platform statistics — reader engagement, accessibility, publication timeliness, keyword breadth, community impact and content distribution — into a single 0–100 figure, recalculated as new articles and metadata are indexed. Dimensions that cannot be measured for this journal are excluded rather than estimated. It is independent of the paid AI Quality Analysis, which never affects this score or the ranking. Full methodology →

About This Journal

Short Name Cancer Med
Abbreviated Name cancer med
ISSN 2045-7634

Quality Profile

7 of 12 dimensions measured
This journal Average of scored journals
Platform statistics — the free Journament Score AI Quality Analysis — separate paid product, ranks nothing

5 of the 12 dimensions could not be measured for this journal. They are left as gaps in the shape rather than plotted as zero.

Show the numbers
Dimension This journal Corpus average
Engagement 30.8 30.1
Accessibility 15.0 17.9
Timeliness 50.0 19.2
Diversity 30.0 28.8
Innovation 40.0 31.2
Community Impact 36.5 13.4
Content Distribution 66.6 88.4
Content Quality — 55.5
Ethics & Transparency — 40.2
Editorial Standards — 33.4
Publication Regularity — 53.2
Geographic Reach — 30.8

Publications Per Year

Articles (22)

2021
Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe)
Gultekin M;Ak S;Ayhan A;Strojna A;Pletnev A;Fagotti A;Perrone AM;Erzeneoglu BE;Temiz BE;Lemley B;Soyak B;Hughes C;Cibula D;Haidopoulos D;Brennan D;Cola E;van der Steen-Banasik E;Urkmez E;Akilli H;Zapardiel I;Tóth I;Sehouli J;Zalewski K;Bahremand K;Chiva L;Mirza MR;Papageorgiou M;Zoltan N;Adámková P;Morice P;Garrido-Mallach S;Akgor U;Theodoulidis V;Arik Z;Steffensen KD;Fotopoulou C;;
Vol. 10 , No. 1 , pp. -
440 views Abstract
2019
Comprehensive analysis of five long noncoding RNAs expression as competing endogenous RNAs in regulating hepatoma carcinoma.
Lou, Xin;Li, Jun;Yu, Dong;Wei, Ya-Qing;Feng, Shuang;Sun, Jin-Jin;
Vol. 8 , No. 12 , pp. 5735-5749
414 views DOI Abstract
2019
Cost-effectiveness of chemoradiation followed by esophagectomy versus chemoradiation alone in squamous cell carcinoma of the esophagus.
Salcedo, Jonathan;Suen, Sze-Chuan;Bian, Shelly X;
388 views DOI Abstract
2017
Diffusion of digital breast tomosynthesis among women in primary care: associations with insurance type.
Clark, Cheryl R;Tosteson, Tor D;Tosteson, Anna N A;Onega, Tracy;Weiss, Julie E;Harris, Kimberly A;Haas, Jennifer S;
Vol. 6 , No. 5 , pp. 1102-1107
364 views DOI Abstract
2020
Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system.
Ikeda, Mio;Koh, Yasuhiro;Teraoka, Shunsuke;Sato, Koichi;Kanai, Kuninobu;Hayata, Atsushi;Tokudome, Nahomi;Akamatsu, Hiroaki;Ozawa, Yuichi;Akamatsu, Keiichiro;Endo, Katsuya;Higuchi, Masayuki;Nakanishi, Masanori;Ueda, Hiroki;Yamamoto, Nobuyuki;
359 views DOI Abstract
2019
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis.
Pugliese, Novella;Giordano, Claudia;Nappi, Davide;Luciano, Luigiana;Cerchione, Claudio;Annunziata, Mario;Casale, Beniamino;Crisà, Elena;Villa, Maria Rosaria;Pezzullo, Luca;Iovine, Maria;Picardi, Marco;Grimaldi, Francesco;Pane, Fabrizio;Martinelli, Vincenzo;
Vol. 8 , No. 6 , pp. 2802-2809
343 views DOI Abstract
2020
Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients.
Wang, Jiangfeng;Luo, Jurui;Jin, Kairui;Wang, Xuanyi;Yang, Zhaozhi;Ma, Jinli;Mei, Xin;Wang, Xiaofang;Zhou, Zhirui;Yu, Xiaoli;Chen, Xingxing;Guo, Xiaomao;
326 views DOI Abstract
2019
RAPTOR promotes colorectal cancer proliferation by inducing mTORC1 and upregulating ribosome assembly factor URB1.
Wang, Tao;Zhang, Wei-Sheng;Wang, Zheng-Xia;Wu, Zhi-Wei;Du, Bin-Bin;Li, Lai-Yuan;Chen, Yi-Feng;Yang, Xiong-Fei;Hao, Xiang-Yong;Guo, Tian-Kang;
321 views DOI Abstract
2019
miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma.
Cui, Rong-Jun;Fan, Jia-Lin;Lin, Yu-Cui;Pan, Yu-Jia;Liu, Chi;Wan, Jia-Hui;Wang, Wei;Jiang, Zheng-Yuan;Zheng, Xiu-Lan;Tang, Jie-Bing;Yu, Xiao-Guang;
321 views DOI Abstract
2020
Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma
Chen, Z.
Vol. 9 , pp. 1392-1399
307 views DOI
2025
Predictors of Financial Toxicity Trajectories in Patients With Pancreatic Cancer: A Latent Class Growth Analysis.
Xiaoxuan, Li; Shuo, Zhang; Shanshan, Li; Mengxia, Yu; Tianying, Yao; Yuxin, Shen; Jiang, Li; Mingxia, Chen
Vol. 14 , pp. e70875
119 views DOI Abstract
2025
Evaluation of Efficacy of Neoadjuvant Immunochemotherapy for Cervical Metastatic Squamous Cell Carcinoma of Unknown Primary.
Gao, Xianlu; Fu, Shuwen; Yang, Chulin; Jiang, Wenmei; Liang, Jiadong; Li, Ruiyu; Yan, Shida; Du, Mingyuan; Yang, Shiyan; Zhang, Quan; Chen, Shuwei
Vol. 14 , pp. e70869
93 views DOI Abstract
2025
Gut Microbiota and Hepatocellular Carcinoma: Metabolic Products and Immunotherapy Modulation.
Xiao, Kunmin; Li, Kexin; Xiao, Kunlin; Yang, Jinzu; Zhou, Lei
Vol. 14 , pp. e70914
48 views DOI Abstract
2023
Gene silencing of Helicobacter pylori through newly designed siRNA convenes the treatment of gastric cancer.
Reza, Mahjerin Nasrin;Mahmud, Shahin;Ferdous, Nadim;Ahammad, Ishtiaque;Hossain, Mohammad Uzzal;Al Amin, Md;Mohiuddin, A K M;
Vol. 12 , No. 24 , pp. 22407-22419
66 views DOI Abstract
2021
Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe)
Gultekin M;Ak S;Ayhan A;Strojna A;Pletnev A;Fagotti A;Perrone AM;Erzeneoglu BE;Temiz BE;Lemley B;Soyak B;Hughes C;Cibula D;Haidopoulos D;Brennan D;Cola E;van der Steen-Banasik E;Urkmez E;Akilli H;Zapardiel I;Tóth I;Sehouli J;Zalewski K;Bahremand K;Chiva L;Mirza MR;Papageorgiou M;Zoltan N;Adámková P;Morice P;Garrido-Mallach S;Akgor U;Theodoulidis V;Arik Z;Steffensen KD;Fotopoulou C;;
Vol. 10 , No. 1 , pp. -
440 views Abstract
2020
Impact of somatic mutations on prognosis in resected non-small-cell lung cancer: The Japan Molecular Epidemiology for lung cancer study
Tamiya, A.
Vol. 9 , pp. 2343-2351
207 views DOI
2020
Risk prediction model for lung cancer incorporating metabolic markers: Development and internal validation in a Chinese population.
Lyu, Zhangyan;Li, Ni;Chen, Shuohua;Wang, Gang;Tan, Fengwei;Feng, Xiaoshuang;Li, Xin;Wen, Yan;Yang, Zhuoyu;Wang, Yalong;Li, Jiang;Chen, Hongda;Lin, Chunqing;Ren, Jiansong;Shi, Jufang;Wu, Shouling;Dai, Min;He, Jie;
304 views DOI Abstract
2020
The case for philanthropic investment to increase colorectal cancer screening rates: A novel paradigm to address a public health challenge.
Carmeli, Ariel;Dranikoff, Lee;Kundu, Arnab;Ladabaum, Uri;
Vol. 9 , No. 3 , pp. 1220-1229
275 views DOI Abstract
2020
Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma
Chen, Z.
Vol. 9 , pp. 1392-1399
307 views DOI
2020
Breast cancer stromal clotting activation (Tissue Factor and thrombin): A pre-invasive phenomena that is prognostic in invasion
Shaker, H.
, pp. 0-0
228 views DOI
Journament Score
38.2/100 · Poor
Ranked #10,051 of 29,341 scored
(33,995 journals indexed)
Platform Statistics
AI Quality Analysis
Separate paid analysis — does not affect ranking.
Journament

Overall Quality Score

38.2/100

Tier: Poor

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

30.8/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

15.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

30.0/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

40.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

36.5/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

50.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Content Distribution

66.6/100

Measures how evenly reader attention spreads across the journal's articles, using the Gini coefficient of article clicks.

Higher scores mean readership is distributed across many articles rather than concentrated on one or two.

Ethics & Transparency Score

Not yet measured

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

Not yet measured

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

Not yet measured

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

Not yet measured

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

Not yet measured

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.